Novo Nordisk to Establish New Production Facility in Denmark with $1.2 Billion Investment
16 December 2024: Novo Nordisk, a leading global healthcare company has unveiled plans to invest $1.2 bn in the construction of a brand-new production facility in Odense, Denmark. This project marks the company’s first establishment of a new production site in Denmark in over two decades, underscoring a